Co-magaldrox (Magnesium/aluminium hydroxide) Prescribing at CLOVER GROUP PRACTICE
Dyspepsia and gastro-oesophageal reflux disease | Gastro-Intestinal System
Items (12m)
41
Total Quantity
20.5K
NHS Cost
£123
vs National Avg
+406%
CLOVER GROUP PRACTICE prescribed 41 items of Co-magaldrox (Magnesium/aluminium hydroxide) over the last 12 months at a cost of £123 to the NHS. This is 406% above the national average prescribing rate. Co-magaldrox (Magnesium/aluminium hydroxide) is classified under Dyspepsia and gastro-oesophageal reflux disease in the BNF.
Monthly Prescribing Trend
No monthly data available.
Prescribing Details
| Total Items | 41 |
|---|---|
| Total Quantity | 20,500 |
| Total NHS Cost | £123 |
| Presentations | 3 different forms |
| vs National Average | +406% |
Co-magaldrox (Magnesium/aluminium hydroxide) Prescribing Comparison
| This practice | 41 items |
|---|---|
| National average per practice | 8 items |
| Difference | +406% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.